USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Medical Optics Inc.

USPTO PatentsView assignee record - 123 granted patents across 43 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

123

Total patents granted

CPC technology areas

15.7

Avg claims per patent

-100%

5-year filing velocity

The verdict

Abbott holds 123 US patents across 43 technology areas, rank #3,075 of 50,000 tracked assignees.

#3,075
of 50,000 US assignees by volume: Top 15%
by Innovation Score (49.2/100): 15.7
avg claims per patent: -100%
filing velocity, last 5 yrs

Portfolio overview

Abbott Medical Optics Inc. has been granted 123 US utility patents between 2015 and 2018, placing Abbott Medical Optics Inc. at rank #3,075 across all assignees tracked by PlainPatent. This portfolio spans 43 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Abbott Medical Optics Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Abbott sits between Inteplast Group Corporation (124 patents, rank #3,071) and Futaba Industrial Co., Ltd. (123 patents, rank #3,079) - the closest US assignees by grant volume. The composite Innovation Score of 49.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 123 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Abbott Medical Optics Inc.'s 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 43 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Abbott Medical Optics Inc. against peers pursuing similar technology classes.

Inteplast Group

124
Mölnlycke Health…

124
Oceaneering Inter…

124
Trudell Medical I…

124
Endress+Hauser +KG

123
Endochoice

123
Everi Games

123
Futaba Industrial

123
Abbott Medical Op… ◀

123

What this shows Abbott holds 123 patents at rank #3,075, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #3,075 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Abbott's primary technology class.

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abbott Medical Optics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	34	27.6%
2016	40	32.5%
2017	43	35.0%
2018	6	4.9%

Which technologies does Abbott Medical Optics Inc. patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 98

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 37

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 27

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 13

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 11

G02C - SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES 8

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 6

G02B - OPTICAL ELEMENTS, SYSTEMS OR APPARATUS 5

G06F - ELECTRIC DIGITAL DATA PROCESSING 5

B06B - METHODS OR APPARATUS FOR GENERATING OR TRANSMITTING MECHANICAL VIBRATIONS OF INFRASONIC, SONIC, OR ULTRASONIC FREQUENCY, ; e.g.; FOR PERFORMING MECHANICAL WORK IN GENERAL 5

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 4

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 3

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 3

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 3

A47B - TABLES; DESKS; OFFICE FURNITURE; CABINETS; DRAWERS; GENERAL DETAILS OF FURNITURE 3

Top 15 of 43 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#3,075

Across all tracked assignees

Innovation Score

49.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Abbott Medical Optics Inc. hold?

Abbott Medical Optics Inc. holds 123 US granted patents filed between 2015 and 2018, spanning 43 technology areas.

What is Abbott Medical Optics Inc.'s Innovation Score?

Abbott Medical Optics Inc. has an Innovation Score of 49.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abbott Medical Optics Inc. focus on?

Abbott Medical Optics Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 98 patents. The company has filed patents in 43 CPC subclasses total.

Is Abbott Medical Optics Inc.'s patent filing rate increasing or decreasing?

Abbott Medical Optics Inc.'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Abbott Medical Optics Inc.'s patents?

Abbott Medical Optics Inc.'s patents average 15.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Abbott Medical Optics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Abbott's 123 grants land it in the top 15% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Abbott ranks #3,075 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.